Expression levels of B cell surface immunoglobulin regulate efficiency of allelic exclusion and size of autoreactive B-1 cell compartment

Journal of Experimental Medicine

Volumn 190, Issue 4, 1999, Pages 461-469

  Watanabe, Norihiko ^a   Nisitani, Sazuku ^a,c   Ikuta, Koichi ^a   Suzuki, Misao ^b   Chiba, Tsutomu ^a   Honjo, Tasuku ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anti RBC antibody; Flow cytometry; Homozygosity; Transgenic lines

Indexed keywords

ERYTHROCYTE ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE LOCUS; HETEROZYGOSITY; HOMOZYGOSITY; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE;

ALLELES; ANIMALS; AUTOANTIBODIES; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; ERYTHROCYTES; HETEROZYGOTE; HOMOZYGOTE; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; MICE; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, B-CELL; TRANSGENES;

EID: 0033575755     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.4.461     Document Type: Article

References (63)

1. Rajewsky, K. 1996. Clonal selection and learning in the antibody system. Nature. 381:751-758.
2. Kitamura, D., and K. Rajewsky. 1992. Targeted disruption of μ chain membrane exon causes loss of heavy-chain allelic exclusion. Nature. 356:154-156.
3. Storb, U. 1995. Ig gene expression and regulation in Ig transgenic mice. In Immunoglobulin Genes. T. Honjo and W.F. Alt, editors. Academic Press, London. 345-363.
4. Nussenzweig, M.C., A.C. Shaw, E. Sinn, D.B. Danner, K.L. Holmes, H.C. Morse III, and P. Leder. 1987. Allelic exclusion in transgenic mice that express the membrane form of immunoglobulin μ. Science. 236:816-819.
5. Nussenzweig, M.C., A.C. Shaw, E. Sinn, J. Campos-Torres and P. Leder. 1988. Allelic exclusion in transgenic mice carrying mutant human IgM genes. J. Exp. Med. 167:1969-1974.
6. Manz, J., K. Denis, O. Witte, R. Brinster, and U. Storb. 1988. Feedback inhibition of immunoglobulin gene rearrangement by membrane μ, but not by secreted μ, heavy chains. J. Exp. Med. 168:1363-1381.
7. Ritchie, K.A., R.L. Brinster, and U. Storb. 1984. Allelic exclusion and control of endogenous immunoglobulin gene rearrangement in K transgenic mice. Nature. 312:517-520.
8. Stall, A.M., F.G.M. Kroese, F.T. Gadus, D.G. Sieckmann, L.A. Herzenberg, and L.A. Herzenberg. 1988. Rearrangement and expression of endogenous immunoglobulin genes occur in many murine B cells expressing transgenic membrane IgM. Proc. Natl. Acad. Sci. USA. 85:3546-3550.
9. Müller, W., U. Rüther, P. Vieira, J. Hombach, M. Reth, and K. Rajewsky. 1989. Membrane-bound IgM obstructs B cell development in transgenic mice. Eur. J. Immunol. 19: 923-928.
10. Kenny, J.J., F. Finkelman, F. Macchiarini, W.C. Kopp, U. Storb, and D.L. Longo. 1989. Alteration of the B cell surface phenotype, immune response to phosphocholine and the B cell repertoire in M167 μ plus κ transgenic mice. J. Immunol. 142:4466-4474.
11. Rath, S., J. Durdik, R.M. Gerstein, E. Selsing, and A. Nisonoff. 1989. Quantitative analysis of idiotypic mimicry and allelic exclusion in mice with a μ Ig transgene. J. Immunol. 143:2074-2080.
12. Forni, L. 1990. Extensive splenic B cell activation in IgM-transgenic mice. Eur. J. Immunol. 20:983-989.
13. Grandien, A., A. Coutinho, and J. Andersson. 1990. Selective peripheral expansion and activation of B cells expressing endogenous immunoglobulin in μ-transgenic mice. Eur. J. Immunol. 20:991-998.
14. Iacomini, J., N. Yannoutsos, S. Bandyopadhay, and T. Imanishi-Kari. 1991. Endogenous immunoglobulin expression in μ transgenic mice. Int. Immunol. 3:185-196.
15. Lam, K.P., L.A. Herzenberg, and A.M. Stall. 1993. A high frequency of hybridomas from M54 μ heavy chain transgenic mice initially co-express transgenic and rearranged endogenous μ genes. Int. Immunol. 5:1011-1022.
16. Rusconi, S., and G. Köhler. 1985. Transmission and expression of a specific pair of rearranged immunoglobulin μ and κ genes in a transgenic mouse line. Nature. 314:330-334.
17. Carmack, C.E., S.A. Camper, J.J. Mackle, W.U. Gerhard, and M.G. Weigert. 1991. Influence of a Vκ8 L chain transgene on endogenous rearrangements and the immune response to the HA(Sb) determinant on influenza virus. J. Immunol. 147:2024-2033.
18. Okamoto, M., M. Murakami, A. Shimizu, S. Ozaki, T. Tsubata, S. Kumagai, and T. Honjo. 1992. A transgenic model of autoimmune hemolytic anemia. J. Exp. Med. 175: 71-79.
19. Murakami, M., T. Tsubata, M. Okamoto, A. Shimizu, S. Kumagai, H. Imura, and T. Honjo. 1992. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature. 357:77-80.
20. Nisitani, S., T. Tsubata, M. Murakami, M. Okamoto, and T. Honjo. 1993. The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow. J. Exp. Med. 178:1247-1254.
21. Murakami, M., T. Tsubata, R. Shinkura, S. Nisitani, M. Okamoto, H. Yoshioka, T. Usui, S. Miyawaki, and T. Honjo. 1994. Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J. Exp. Med. 180:111-121.
22. Nisitani, S., T. Tsubata, M. Murakami, and T. Honjo. 1995. Administration of interleukin-5 or -10 activates peritoneal B-1 cells and induces autoimmune hemolytic anemia in anti-erythrocyte autoantibody-transgenic mice. Eur. J. Immnnol. 25:3047-3052.
23. Murakami, M., K. Nakajima, K. Yamazaki, T. Muraguchi, T. Serikawa, and T. Honjo. 1997. Effects of breeding environments on generation and activation of autoreactive B-1 cells in anti-red blood cell autoantibody transgenic mice. J. Exp. Med. 185:791-794.
24. Nisitani, S., T. Sakiyama, and T. Honjo. 1998. Involvement of IL-10 in induction of autoimmune hemolytic anemia in anti-erythrocyte Ig transgenic mice. Int. Immunol. 10:1039-1047.
25. Hayakawa, K., R.R. Hardy, D.R. Parks, and L.A. Herzenberg. 1983. The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J. Exp. Med. 157: 202-218.
26. Waldschmidt, T.J., F.G. Kroese, L.T. Tygrett, D.H. Conrad, and R.G. Lynch. 1991. The expression of B cell surface receptors. III. The murine low-affinity IgE Fc receptor is not expressed on Ly 1 or "Ly 1-like" B cells. Int. Immunol. 3:305-315.
27. Hayakawa, K., R.R. Hardy, A.M. Stall, L.A. Herzenberg, and L.A. Herzenberg. 1986. Immunoglobulin-bearing B cells reconstitute and maintain the murine Ly-1 B cell lineage. Eur. J. Immunol. 16:1313-1316.
28. Marcos, M.A., F. Huetz, P. Pereira, J.L. Andreu, A.C. Martinez, and A. Coutinho. 1989. Further evidence for coelomic-associated B lymphocytes. Eur. J. Immunol. 19:2031-2035.
29. Hayakawa, K., R.R. Hardy, M. Honda, L.A. Herzenberg, A.D. Steinberg, and L.A. Herzenberg. 1984. Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc. Natl. Acad. Sci. USA. 81:2494-2498.
30. Lalor, P.A., and G. Morahan. 1990. The peritoneal Ly-1 (CD5) B cell repertoire is unique among murine B cell repertoires. Eur. J. Immunol. 20:485-492.
31. Mercolino, T.J., L.W. Arnold, and G. Haughton. 1986. Phosphatidyl choline is recognized by a series of Ly-1 + murine B cell lymphomas specific for erythrocyte membranes. J. Exp. Med. 163:155-165.
32. Su, S.D., M.M. Ward, M.A. Apicella, and R.E. Ward. 1991. The primary B cell response to the O/core region of bacterial lipopolysaccharide is restricted to the Ly-1 lineage. J. Immunol. 146:327-331.
33. Forster, I., and K. Rajewsky. 1987. Expansion and functional activity of Ly-1 + B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur. J. Immunol. 17:521-528.
34. H repertoires formed at different stages of ontogeny and under different selection pressures. EMBO (Eur. Mol. Biol. Organ.) J. 14:1680-1689.
35. Hayakawa, K., R.R. Hardy, L.A. Herzenberg, and L.A. Herzenberg. 1985. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J. Exp. Med. 161:1554-1568.
36. Kantor, A.B., A.M. Stall, S. Adams, and L.A. Herzenberg. 1992. Differential development of progenitor activity for three B-cell lineages. Proc. Natl. Acad. Sci. USA. 89:3320-3324.
37. Cong, Y.Z., E. Rabin, and H.H. Wortis. 1991. Treatment of murine CD5-B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. Int. Immunol. 3:467-476.
38. + B cells. Eur. J. Immunol. 26:2537-2540.
39. Berland, R., and H.H. Wortis. 1998. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells. J. Immunol. 161:277-285.
40. Arnold, L.W., C.A. Pennell, S.K. McCray, and S.H. Clarke 1994. Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to B-1 population occurs after immunoglobulin gene expression. J. Exp. Med. 179:1585-1595.
41. + B cell precursor in B-1 cell differentiation. J. Exp. Med. 187:1325-1334.
42. Kitamura, D., A. Kudo, S. Schaal, W. Müller, F. Melchers, and K. Rajewsky. 1992. A critical role of λ 5 protein in B cell development. Cell. 69:823-831.
43. Grawunder, U., T.M. Leu, D.G. Schatz, A. Werner, A.G. Rolink, F. Melchers, and T.H. Winkler. 1995. Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity. 3:601-608.
44. Löffert, D., A. Ehlich, W. Müller, and K. Rajewsky. 1996. Surrogate light chain expression is required to establish immunoglobulin heavy chain allelic exclusion during early B cell development. Immunity. 4:133-144.
45. Shaffer, A.L., and M.S. Schlissel. 1997. A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development. J. Immunol. 159:1265-1275.
46. ten Boekel, E., F. Melchers, and A.G. Rolink. 1998. Precursor B cells showing H chain allelic inclusion display allelic exclusion at the level of pre-B cell receptor surface expression. Immunity. 8:199-207.
47. Papavasiliou, F., Z. Misulovin, H Suh, and M.C. Nussenzweig. 1995. The role of Ig β in precursor B cell transition and allelic exclusion. Science. 268:408-411.
48. Papavasiliou, F., M. Jankovic, H. Suh, and M.C. Nussenzweig. 1995. The cytoplasmic domains of immunoglobulin (Ig) α and Ig β can independently induce the precursor B cell transition and allelic exclusion. J. Exp. Med. 182:1389-1394.
49. Teh, Y.M., and M.S. Neuberger. 1997. The immunoglobulin (Ig)α and Igβ cytoplasmic domains are independently sufficient to signal B cell maturation and activation in transgenic mice. J. Exp. Med. 185:1753-1758.
50. Sonoda, E., Y. Pewzner-Jung, S. Schwers, S. Taki, S. Jung, D. Eilat, and K. Rajewsky. 1997. B cell development under the condition of allelic inclusion. Immunity. 6:225-233.
51. Tiegs, S.L., D.M. Russell, and D. Nemazee. 1993. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177:1009-1020.
52. Gay, D., T. Saunders, S. Camper, and M. Weigert. 1993. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177:999-1008.
53. Melamed, D., and D. Nemazee. 1997. Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest. Proc. Natl. Acad. Sci. USA. 94:9267-9272.
54. - bone marrow B cells in vitro. Immunity. 6:429-436.
55. Melamed, D., R. Benschop, J.C. Cambier, and D. Nemazee. 1998. Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection. Cell. 92:173-182.
56. Zhang, R., F.W. Alt, L. Davidson, S.H. Orkin, and W. Swat. 1995. Defective signalling through the T-and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature. 374:470-473.
57. Leitges, M., C. Schmedt, R. Guinamard, J. Davoust, S. Schaal, S. Stabel, and A. Tarakhovsky. 1996. Immunodeficency in protein kinase Cβ-deficient mice. Science. 273: 788-791.
58. + B cells in viable motheaten and normal mice. Science. 232:1423-1425.
59. Shultz, L.D., P.A. Schweitzer, T.V. Rajan, T. Yi, J.N. Ihle, R.J. Matthews, M.L. Thomas, and D.R. Beier. 1993. Mutation at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell. 73:1445-1454.
60. Tsui, H.W., K.A. Siminovitch, L. de Souza, and F.W.L. Tsui. 1993. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat. Genet. 4:124-129.
61. Cyster, J.G., and C.C. Goodnow. 1995. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity. 2:13-24.
62. Pani, G., M. Kozlowski, J.C. Cambier, G.B. Mills, and K.A. Siminovitch. 1995. Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling. J. Exp. Med. 181: 2077-2084.
63. Goodnow, C.C., J. Crosbie, S. Adelstein, T.B. Lavoie, S.J. Smith-Gill, R.A. Brink, H. Pritchard-Briscoe, J.S. Wotherspoon, R.H. Loblay, K. Raphael, et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature. 334:676-682.